- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00727012
Multicenter International Trial Ring AnnulopLasty (MITRAL)
February 1, 2019 updated by: Abbott Medical Devices
This clinical study is a multicenter, prospective non-randomized observational study without concurrent or matched controls in which 150 patients receiving an SJM® Rigid Saddle Ring will be included.
The primary objective of the study is to demonstrate the effectiveness of the SJM® Rigid Saddle Ring when used in mitral valve repair procedures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- University of Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient requiring a mitral valve repair due to mitral degenerative or functional disease (Note: Patients that underwent concomitant procedures, e.g. coronary artery bypass grafting, are eligible for this study);
- Patient (or legal guardian) has signed a study specific informed consent form agreeing to the data collection and follow-up requirements;
- Patients are at least 18 years old.
Exclusion Criteria:
- Patient requires replacement of the aortic, tricuspid or pulmonary valve or has a pre-existing prosthetic valve;
- Patient is pregnant or nursing;
- Patient has active endocarditis;
- Patient is actively participating in another study of an investigational drug or device;
- Patients unavailable to follow-up visit (abroad residents, patients affected by neurological disorders...);
- Patients who are intravenous drug abusers, alcohol abusers, prison inmates or unable to give informed consent;
- Patients with a major non-cardiac evolving disease;
- Patients with a life expectancy less than 1 year;
- Patients are known to be noncompliant or are unlikely to complete the study;
- Any case in which mitral annuloplasty rings are not indicated;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: SJM® Rigid Saddle Ring
The SJM® Rigid Saddle Ring is an annuloplasty ring comprised of a titanium core surrounded by a double-velour, polyester fabric sewing cuff.
|
mitral valve repair due to mitral degenerative or functional disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
NYHA class
Time Frame: 6 months
|
6 months
|
|
Change in ERO (Effective Regurgitant Orifice) in cm2 calculated with PISA method at 6 months and at patient discharge compared to baseline (pre-operative).
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
adverse events rates
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Raffaele De Simone, Prof. Dr., Heidelberg University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
November 1, 2010
Study Completion (Actual)
November 1, 2010
Study Registration Dates
First Submitted
July 29, 2008
First Submitted That Met QC Criteria
July 31, 2008
First Posted (Estimate)
August 1, 2008
Study Record Updates
Last Update Posted (Actual)
February 4, 2019
Last Update Submitted That Met QC Criteria
February 1, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CS06003RG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Valve Insufficiency
-
Abbott Medical DevicesCompletedMitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With InsufficiencyJapan
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Bordeaux; Montreal Heart InstituteRecruitingMitral Regurgitation | Mitral Valve Disease | Mitral Annular CalcificationSwitzerland, United States, Denmark, United Kingdom, France, Austria, Canada, Italy, Germany, Greece, Poland, Australia, Norway
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States, Spain, Germany, Greece
-
Abbott Medical DevicesActive, not recruitingCardiovascular Diseases | Heart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Valve Disease, Heart | Mitral Insufficiency | Functional Mitral Regurgitation | Degenerative Mitral Valve DiseaseCanada, United States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesRecruiting
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
Clinical Trials on mitral valve repair (SJM® Rigid Saddle Ring)
-
Abbott Medical DevicesRecruitingMitral Regurgitation | Valvular Heart Disease | Tricuspid RegurgitationEstonia, France, Germany, Italy, Spain, Netherlands, United States
-
Abbott Medical DevicesCompletedMitral Valve ProlapseUnited Kingdom
-
Shanghai NewMed Medical Co., Ltd.Recruiting
-
Medtentia International Ltd OyTerminatedMitral Regurgitation | Mitral InsufficiencyFinland
-
Enlight Medical Technologies (Shanghai) Co., LtdActive, not recruitingDegenerative Mitral Valve DiseaseChina
-
Meshalkin Research Institute of Pathology of CirculationCompletedMitral Regurgitation
-
Lundquist Institute for Biomedical Innovation at...Active, not recruitingSleep RestrictionUnited States